An increase of 49 million shares, or 30% from 1/1/19 to 11/08/19. Some might consider that increase to be significant. The share price only went from .10 to .09 during that exact same time period. So if the insignificant 30% increase in shares didn't account for the 10% pps decrease, I would love to hear the other factors you think are causing it.
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-inc-IPIX/stock-news/80831043/annual-report-10-k
The aggregate market value of the registrant’s voting and non-voting common equity held by non-affiliates on December 31, 2018 was $16,326,577 (163,265,767 shares), based on the closing price of the registrant’s common stock of $0.10.
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-inc-IPIX/stock-news/81135230/quarterly-report-10-q
The number of shares outstanding of each of the issuer’s classes of common equity, as of November 8, 2019 is as follows:
Class of Securities
Shares Outstanding
Common Stock Class A, $0.0001 par value
212,369,124
News 
Market Data 
Discover 
AI
